JP2011523642A5 - - Google Patents

Download PDF

Info

Publication number
JP2011523642A5
JP2011523642A5 JP2011509995A JP2011509995A JP2011523642A5 JP 2011523642 A5 JP2011523642 A5 JP 2011523642A5 JP 2011509995 A JP2011509995 A JP 2011509995A JP 2011509995 A JP2011509995 A JP 2011509995A JP 2011523642 A5 JP2011523642 A5 JP 2011523642A5
Authority
JP
Japan
Prior art keywords
seq
expression vector
replicase
adjuvant
vaccine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011509995A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011523642A (ja
JP5663474B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/056240 external-priority patent/WO2009141434A1/en
Publication of JP2011523642A publication Critical patent/JP2011523642A/ja
Publication of JP2011523642A5 publication Critical patent/JP2011523642A5/ja
Application granted granted Critical
Publication of JP5663474B2 publication Critical patent/JP5663474B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011509995A 2008-05-23 2009-05-22 アルファウイルスレプリカーゼをコードする発現ベクターおよび免疫アジュバントとしてのその使用 Expired - Fee Related JP5663474B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7189808P 2008-05-23 2008-05-23
US61/071,898 2008-05-23
PCT/EP2009/056240 WO2009141434A1 (en) 2008-05-23 2009-05-22 Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant

Publications (3)

Publication Number Publication Date
JP2011523642A JP2011523642A (ja) 2011-08-18
JP2011523642A5 true JP2011523642A5 (https=) 2013-05-23
JP5663474B2 JP5663474B2 (ja) 2015-02-04

Family

ID=40910781

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011509995A Expired - Fee Related JP5663474B2 (ja) 2008-05-23 2009-05-22 アルファウイルスレプリカーゼをコードする発現ベクターおよび免疫アジュバントとしてのその使用

Country Status (15)

Country Link
US (1) US9474800B2 (https=)
EP (1) EP2296702A1 (https=)
JP (1) JP5663474B2 (https=)
KR (1) KR20110044836A (https=)
CN (1) CN102083463B (https=)
AU (1) AU2009248735B2 (https=)
BR (1) BRPI0913045A2 (https=)
CA (1) CA2724570A1 (https=)
IL (1) IL209077A0 (https=)
MX (1) MX2010012587A (https=)
NZ (1) NZ589495A (https=)
RU (1) RU2010152562A (https=)
SG (1) SG191600A1 (https=)
WO (1) WO2009141434A1 (https=)
ZA (1) ZA201007880B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201220119D0 (en) * 2012-11-08 2012-12-26 Univ Cork Vector
CN111304201B (zh) * 2020-02-21 2022-10-21 华南农业大学 一种降低乙型脑炎脑病毒感染的siRNA及其应用
WO2021183563A1 (en) 2020-03-09 2021-09-16 Arcturus Therapeutics, Inc. Coronavirus vaccine compositions and methods
US12178921B2 (en) 2020-08-14 2024-12-31 Arcturus Therapeutics, Inc. Method of lyophilizing lipid nanoparticles
CN113846113B (zh) * 2021-09-09 2022-09-13 臻赫医药(杭州)有限公司 一种有限自我复制mRNA分子系统、制备方法及应用
JP2025504364A (ja) * 2022-01-08 2025-02-12 カロジェン コーポレイション 慢性b型肝炎感染症を処置または防止するための複数抗原治療ワクチン
KR20240049429A (ko) 2022-10-08 2024-04-16 최주언 황금비율 계량컵

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763584A (en) * 1992-05-18 1998-06-09 Genentech, Inc. Receptor activation with hepatocyte growth factor agonists
SE9401091D0 (sv) * 1994-03-31 1994-03-31 Bioption Ab Alphavirus cDNA vectors
SE9401709D0 (sv) * 1994-05-18 1994-05-18 Mathilda Sjoeberg Improved alphavirus vectors for expression of heterologous DNA
JP2002521461A (ja) * 1998-07-29 2002-07-16 インビトロゲン・コーポレーション Rnaウイルスを用いる組換えタンパク質の調節発現
AU7938900A (en) 1999-10-27 2001-05-08 Cytos Biotechnology Ag Method for creating divergent populations of nucleic acid molecules and proteins
JP4450555B2 (ja) * 2000-12-28 2010-04-14 協和発酵キリン株式会社 新規モノクローナル抗体
FI116851B (fi) * 2001-05-03 2006-03-15 Fit Biotech Oyj Plc Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita
EP1530585A2 (en) * 2002-08-22 2005-05-18 Cytos Biotechnology AG Inducible alphaviral/orip based gene expression system
ES2222095B1 (es) * 2003-07-02 2005-11-16 Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria Inia Virus adn recombinantes que comprenden un adn complementario de un replicon de un virus arn y sus aplicaciones.
CA2572921C (en) * 2004-07-09 2017-01-03 The University Of North Carolina At Chapel Hill Replication-competent and propagation-defective venezuelan equine encephalitis (vee) viral adjuvants
AU2007342333B2 (en) * 2006-09-12 2013-02-28 Alphavax, Inc. Alphavirus replicon particles encoding IL- 12 as immunological adjuvants
EP2097533B9 (en) * 2006-11-28 2010-12-22 Proyecto de Biomedicina Cima, S.L. Viral vector and uses thereof
WO2008119827A1 (en) * 2007-04-02 2008-10-09 Fit Biotech Oy Transreplicase constructs

Similar Documents

Publication Publication Date Title
JP2021182922A5 (https=)
JP2011523642A5 (https=)
Pugachev et al. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection
JP5065024B2 (ja) Tc−83由来アルファウイルスベクター、粒子および方法
CN111630060B (zh) 用于在疾病的预防和/或治疗中使用的疫苗
JP2873880B2 (ja) ポックスウイルス成分の組み合わせにもとづく類属免疫誘導剤、その製造方法
JP2017503482A5 (https=)
MX2009008118A (es) Polipeptido e2 del virus del papiloma usado para vacunacion.
JP2012509678A5 (https=)
JPH05502999A (ja) 治療用リボザイム組成物および発現ベクター
JP2016513115A5 (https=)
US20210205436A1 (en) Recombinant mopeia virus and vaccine platform
EA003554B1 (ru) Фармацевтическая композиция для генерации противовирусного иммунного ответа у человека и животного
JP2013502225A5 (https=)
WO2009141434A4 (en) Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant
RU2015113826A (ru) Выделение вируса, родственного парвовирусу-2 собак, от енота
Cervantes-Barragan et al. Dendritic cell-specific antigen delivery by coronavirus vaccine vectors induces long-lasting protective antiviral and antitumor immunity
US8765143B2 (en) Fusion proteins and use thereof for preparing hepatitis C vaccines
JP7841847B2 (ja) ラッサワクチン
JP2017518058A (ja) 弱毒rnaウイルスの迅速な生成のための方法
CN102746387B (zh) 一种hcv的dna疫苗及其制备方法
CN112501138A (zh) 用于快速制备感染性rna病毒的方法
WO2009126308A3 (en) Compositions and methods for vaccine and virus production
WO2004072274A1 (en) Virus-like particle vaccine containing dengue virus recombinant replicon as its carrier
US20100322965A1 (en) Viral vaccine vectors